Biotricity, Inc. (BTCY)

USD 0.5

(2.04%)

Revenue Summary of Biotricity, Inc.

  • Biotricity, Inc.'s latest annual revenue in 2024 was 12.06 Million USD , up 25.15% from previous year.
  • Biotricity, Inc.'s latest quarterly revenue in 2024 FY was 12.06 Million USD , up 25.15% from previous quarter.
  • Biotricity, Inc. reported a annual revenue of 9.63 Million USD in annual revenue 2023, up 26.0% from previous year.
  • Biotricity, Inc. reported a annual revenue of 7.65 Million USD in annual revenue 2022, up 126.02% from previous year.
  • Biotricity, Inc. reported a quarterly revenue of 3.02 Million USD for 2024 Q1, up 10.15% from previous quarter.
  • Biotricity, Inc. reported a quarterly revenue of 2.97 Million USD for 2024 Q3, up 2.82% from previous quarter.

Annual Revenue Chart of Biotricity, Inc. (2024 - 2014)

Historical Annual Revenue of Biotricity, Inc. (2024 - 2014)

Year Revenue Revenue Growth
2024 12.06 Million USD 25.15%
2023 9.63 Million USD 26.0%
2022 7.65 Million USD 126.02%
2021 3.38 Million USD 138.75%
2020 1.41 Million USD 256.03%
2019 398.2 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%

Peer Revenue Comparison of Biotricity, Inc.

Name Revenue Revenue Difference
Acutus Medical, Inc. 7.16 Million USD -68.388%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 32.53 Million USD 62.921%
Nemaura Medical Inc. 77.04 Thousand USD -15557.735%
PetVivo Holdings, Inc. 968.7 Thousand USD -1145.305%
RetinalGenix Technologies Inc. - USD -Infinity%
Sonendo, Inc. 43.86 Million USD 72.499%
Telesis Bio, Inc. 27.5 Million USD 56.148%
Talis Biomedical Corporation 412 Thousand USD -2827.996%
Viveve Medical, Inc. 6.42 Million USD -87.727%